Hepatobiliary system-liver and pancreas and gall bladder and ducts, via natural or artificial opening: códigos SUNAT

85813100 Hepatobiliary system-liver and pancreas and gall bladder and ducts, via natural or artificial opening

• 85813101Introduction of nonautologous pancreatic islet cells into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813102Introduction of autologous pancreatic islet cells into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813103Introduction of destructive agent into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813104Introduction of other gas into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813105Introduction of analgesics, hypnotics, sedatives into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813106Introduction of other diagnostic substance into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813107Introduction of radioactive substance into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813108Introduction of other therapeutic substance into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813109Introduction of local anesthetic into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813110Introduction of electrolytic and water balance substance into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813111Introduction of nutritional substance into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813112Introduction of anti-inflammatory into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813113Introduction of other anti-infective into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813114Introduction of oxazolidinones into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813115Introduction of monoclonal antibody into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813116Introduction of other antineoplastic into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813117Introduction of liquid brachytherapy radioisotope into biliary and pancreatic tract, via natural or artificial opening endoscopic
• 85813118Introduction of nonautologous pancreatic islet cells into biliary and pancreatic tract, via natural or artificial opening
• 85813119Introduction of autologous pancreatic islet cells into biliary and pancreatic tract, via natural or artificial opening
• 85813120Introduction of destructive agent into biliary and pancreatic tract, via natural or artificial opening
• 85813121Introduction of other gas into biliary and pancreatic tract, via natural or artificial opening
• 85813122Introduction of analgesics, hypnotics, sedatives into biliary and pancreatic tract, via natural or artificial opening
• 85813123Introduction of other diagnostic substance into biliary and pancreatic tract, via natural or artificial opening
• 85813124Introduction of radioactive substance into biliary and pancreatic tract, via natural or artificial opening
• 85813125Introduction of other therapeutic substance into biliary and pancreatic tract, via natural or artificial opening
• 85813126Introduction of local anesthetic into biliary and pancreatic tract, via natural or artificial opening
• 85813127Introduction of electrolytic and water balance substance into biliary and pancreatic tract, via natural or artificial opening
• 85813128Introduction of nutritional substance into biliary and pancreatic tract, via natural or artificial opening
• 85813129Introduction of anti-inflammatory into biliary and pancreatic tract, via natural or artificial opening
• 85813130Introduction of other anti-infective into biliary and pancreatic tract, via natural or artificial opening
• 85813131Introduction of oxazolidinones into biliary and pancreatic tract, via natural or artificial opening
• 85813132Introduction of monoclonal antibody into biliary and pancreatic tract, via natural or artificial opening
• 85813133Introduction of other antineoplastic into biliary and pancreatic tract, via natural or artificial opening
• 85813134Introduction of liquid brachytherapy radioisotope into biliary and pancreatic tract, via natural or artificial opening